364 related articles for article (PubMed ID: 28601390)
1. Frequency of and risk factors for tumor upstaging after wide local excision of primary cutaneous melanoma.
Etzkorn JR; Sharkey JM; Grunyk JW; Shin TM; Sobanko JF; Miller CJ
J Am Acad Dermatol; 2017 Aug; 77(2):341-348. PubMed ID: 28601390
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for positive or equivocal margins after wide local excision of 1345 cutaneous melanomas.
Miller CJ; Shin TM; Sobanko JF; Sharkey JM; Grunyk JW; Elenitsas R; Chu EY; Capell BC; Ming ME; Etzkorn JR
J Am Acad Dermatol; 2017 Aug; 77(2):333-340.e1. PubMed ID: 28711085
[TBL] [Abstract][Full Text] [Related]
3. Clinical factors associated with subclinical spread of in situ melanoma.
Shin TM; Etzkorn JR; Sobanko JF; Margolis DJ; Gelfand JM; Chu EY; Elenitsas R; Shaikh WR; Miller CJ
J Am Acad Dermatol; 2017 Apr; 76(4):707-713. PubMed ID: 28073583
[TBL] [Abstract][Full Text] [Related]
4. Frequency of and factors associated with positive or equivocal margins in conventional excision of atypical intraepidermal melanocytic proliferations (AIMP): A single academic institution cross-sectional study.
Zhang J; Miller CJ; Sobanko JF; Shin TM; Etzkorn JR
J Am Acad Dermatol; 2016 Oct; 75(4):688-695. PubMed ID: 27421628
[TBL] [Abstract][Full Text] [Related]
5. Upstaging of melanoma in situ and lentigo maligna treated with Mohs micrographic surgery rarely results in additional surgical management.
Levoska MA; Schmults CD; Waldman AH
Arch Dermatol Res; 2020 Dec; 312(10):753-756. PubMed ID: 32002653
[TBL] [Abstract][Full Text] [Related]
6. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
McKenna DB; Lee RJ; Prescott RJ; Doherty VR
Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
[TBL] [Abstract][Full Text] [Related]
7. Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining for atypical intraepidermal melanocytic proliferation.
Etzkorn JR; Jew OS; Shin TM; Sobanko JF; Neal DE; Miller CJ
J Am Acad Dermatol; 2018 Dec; 79(6):1109-1116.e1. PubMed ID: 30003986
[TBL] [Abstract][Full Text] [Related]
8. Benefit of Mohs Micrographic Surgery Over Wide Local Excision for Melanoma of the Head and Neck: A Rational Approach to Treatment.
Demer AM; Vance KK; Cheraghi N; Reich HC; Lee PK
Dermatol Surg; 2019 Mar; 45(3):381-389. PubMed ID: 30550523
[TBL] [Abstract][Full Text] [Related]
9. Frequency of residual melanoma in wide local excision (WLE) specimens after complete excisional biopsy.
Bolshinsky V; Lin MJ; Serpell J; Leung M; Wolfe R; McLean C; Kelly JW
J Am Acad Dermatol; 2016 Jan; 74(1):102-7. PubMed ID: 26601566
[TBL] [Abstract][Full Text] [Related]
10. Upstaging From Melanoma in Situ to Invasive Melanoma on the Head and Neck After Complete Surgical Resection.
Gardner KH; Hill DE; Wright AC; Brewer JD; Arpey CJ; Otley CC; Roenigk RK; Baum CL
Dermatol Surg; 2015 Oct; 41(10):1122-5. PubMed ID: 26356849
[TBL] [Abstract][Full Text] [Related]
11. Delay of Surgery for Melanoma Among Medicare Beneficiaries.
Lott JP; Narayan D; Soulos PR; Aminawung J; Gross CP
JAMA Dermatol; 2015 Jul; 151(7):731-41. PubMed ID: 25853865
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors Predicting Positive Margins at Primary Wide Local Excision of Cutaneous Melanoma.
Mangold AR; Skinner R; Dueck AC; Sekulic A; Pockaj BA
Dermatol Surg; 2016 May; 42(5):646-52. PubMed ID: 27082057
[TBL] [Abstract][Full Text] [Related]
13. Melanoma of the ear: prognostic factors and surgical strategies.
Jahn V; Breuninger H; Garbe C; Moehrle M
Br J Dermatol; 2006 Feb; 154(2):310-8. PubMed ID: 16433802
[TBL] [Abstract][Full Text] [Related]
14. Effect of biopsy type on outcomes in the treatment of primary cutaneous melanoma.
Mills JK; White I; Diggs B; Fortino J; Vetto JT
Am J Surg; 2013 May; 205(5):585-90; discussion 590. PubMed ID: 23592167
[TBL] [Abstract][Full Text] [Related]
15. Impact of Biopsy Modality on the Management of Cutaneous Melanoma of the Head and Neck.
Namin AW; Zitsch RP
Otolaryngol Head Neck Surg; 2018 Mar; 158(3):473-478. PubMed ID: 29110565
[TBL] [Abstract][Full Text] [Related]
16. Low recurrence rates for in situ and invasive melanomas using Mohs micrographic surgery with melanoma antigen recognized by T cells 1 (MART-1) immunostaining: tissue processing methodology to optimize pathologic staging and margin assessment.
Etzkorn JR; Sobanko JF; Elenitsas R; Newman JG; Goldbach H; Shin TM; Miller CJ
J Am Acad Dermatol; 2015 May; 72(5):840-50. PubMed ID: 25774012
[TBL] [Abstract][Full Text] [Related]
17. A targeted approach to sentinel lymph node biopsies in the parotid region for head and neck melanomas.
Samra S; Sawh-Martinez R; Tom L; Colebunders B; Salameh B; Truini C; Ariyan S; Narayan D
Ann Plast Surg; 2012 Oct; 69(4):415-7. PubMed ID: 22964672
[TBL] [Abstract][Full Text] [Related]
18. 1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.
Moncrieff MD; Gyorki D; Saw R; Spillane AJ; Thompson JF; Peach H; Oudit D; Geh J; Dziewulski P; Wilson E; Matteucci P; Pritchard-Jones R; Olofsson Bagge R; Wright FC; Crampton N; Cassell O; Jallali N; Berger A; Kelly J; Hamilton S; Durrani A; Lo S; Paton E; Henderson MA
Ann Surg Oncol; 2018 Sep; 25(9):2541-2549. PubMed ID: 29850955
[TBL] [Abstract][Full Text] [Related]
19. Surgical management of primary cutaneous melanomas of the hands and feet.
Tseng JF; Tanabe KK; Gadd MA; Cosimi AB; Malt RA; Haluska FG; Mihm MC; Sober AJ; Souba WW
Ann Surg; 1997 May; 225(5):544-50; discussion 550-3. PubMed ID: 9193182
[TBL] [Abstract][Full Text] [Related]
20. Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.
Davis-Malesevich MV; Goepfert R; Kubik M; Roberts DB; Myers JN; Kupferman ME
Head Neck; 2015 Aug; 37(8):1116-21. PubMed ID: 24764188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
